Goat anti-Human Kappa Light Chain Secondary Antibody [Biotin] (Pre-adsorbed)
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-75062
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Biotin
Antibody Source
Polyclonal Goat IgG
Format
Pre-adsorbed
Concentration
1.5 mg/ml
Product Specifications
Immunogen
Purified Human Kappa light chain
Reactivity Notes
Based on IEP, no reactivity is observed to non-immunoglobulin human serum proteins, heavy chains on all human immunoglobulins, and lambda light chains on all human immunoglobulins
Specificity
Based on IEP, this antibody reacts with kappa and light chains on all human immunoglobulins. This antibody has been pre-adsorbed against mouse serum proteins.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Description
Purity > 95% based on SDS-PAGE. Goat serum was obtained from healthy animals of US origin and under the care of a registered veterinarian.
Applications
Application
Recommended Usage
ELISA
1:2000 - 1:20000
Immunohistochemistry
1:500 - 1:5000
Western Blot
1:2000 - 1:20000
Application Notes
This conjugate is suitable for all immunoassay applications.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free
Format
Pre-adsorbed
Preservative
0.05% Sodium Azide
Concentration
1.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: Kappa Light Chain
Alternate Names
HCAK1, IGKCD, immunoglobulin kappa constant, Km, MGC111575, MGC62011, MGC72072, MGC88770, MGC88771, MGC88809
Gene Symbol
IGKC
Additional Kappa Light Chain Products
Product Specific Notices
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Secondary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...